A MEDIATION ANALYSIS OF DYNAMIC PROCESS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS B PATIENTS WITH ANTIVIRAL TREATMENT

被引：0
|
作者：
Cho, Minjoo [1 ]
Choi, Jonggi [1 ]
Lee, Yeojin [1 ]
Hong, Hyeyeon [1 ]
Yang, Jiwon [1 ]
Chung, Sung Won [1 ]
Choi, Won-Mook [1 ]
Lee, Danbi [1 ]
Shim, Ju Hyun [2 ]
Kim, Kang Mo [2 ]
Lim, Young-Suk [3 ]
Lee, Han Chu [1 ]
Han, Seungbong [4 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Liver, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[4] Korea Univ, Seoul, South Korea
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1399C
引用
收藏
页码：S501 / S501
页数：1
相关论文
共 50 条
  • [31] Development of prediction model for hepatocellular carcinoma in chronic hepatitis B patients
    Ungtrakul, T.
    Soonklang, K.
    Dechma, J.
    Kusuman, P.
    Pongpun, W.
    ANNALS OF ONCOLOGY, 2019, 30
  • [32] On-treatment predictors of hepatocellular carcinoma in patients with chronic hepatitis B
    Peng, Cheng-Yuan
    Chen, Chien-Hung
    LIVER INTERNATIONAL, 2021, 41 (07) : 1700 - 1701
  • [33] Risk prediction models for hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy: A meta-analysis
    Shen, Yueli
    Liu, Jiao
    Han, Zhi
    Jiang, Weiyun
    Cui, Huaizhong
    Xun, Yunhao
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (06)
  • [34] Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population
    Gordon, Stuart C.
    Lamerato, Lois E.
    Rupp, Loralee B.
    Li, Jia
    Holmberg, Scott D.
    Moorman, Anne C.
    Spradling, Philip R.
    Teshale, Eyasu H.
    Vijayadeva, Vinutha
    Boscarino, Joseph A.
    Henkle, Emily M.
    Oja-Tebbe, Nancy
    Lu, Mei
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (05) : 885 - 893
  • [35] Reduction of Cirrhosis and Hepatocellular Carcinoma With Antiviral Therapy in Chronic Hepatitis B
    Liaw, Yun-Fan
    HEPATOLOGY, 2013, 58 (05) : 1856 - 1856
  • [36] In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B
    Keskin, O.
    Idilman, R.
    Kalkan, C.
    Karakaya, M. F.
    Caliskan, A.
    Yurdaydin, C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S687 - S688
  • [37] Antiviral Therapy and the Development of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B (CHB) Patients with and without Cirrhosis in a US Population
    Lin, Derek
    Nguyen, Nghia H.
    Hoang, Joseph
    Vu, Vinh D.
    Trinh, Huy N.
    Li, Jiayi
    Zhang, Jian Q.
    Nguyen, Huy A.
    Khanh Nguyen
    Nguyen, Mindie H.
    HEPATOLOGY, 2014, 60 : 988A - 988A
  • [38] Comparable outcomes between Besifovir and other antiviral therapies in hepatocellular carcinoma development among patients with chronic hepatitis B
    Lee, Jae Seung
    Lee, Won
    Kim, Sang Gyune
    Seo, Yeon Seok
    Yu, Su Jong
    Yim, Hyung Joon
    Lee, Hye Won
    Kim, Mi Na
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    JOURNAL OF HEPATOLOGY, 2024, 80 : S799 - S799
  • [39] COMPARABLE OUTCOMES BETWEEN BESIFOVIR AND OTHER ANTIVIRAL THERAPIES IN HEPATOCELLULAR CARCINOMA DEVELOPMENT AMONG PATIENTS WITH CHRONIC HEPATITIS B
    Lee, Jae Seung
    Lee, Sung Won
    Kim, Sang Gyune
    Seo, Yeon Seok
    Yu, Su Jong
    Yim, Hyung Joon
    Lee, Hye Won
    Kim, Mi Na
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    HEPATOLOGY, 2024, 80 : S293 - S294
  • [40] MeCP2 level is associated with hepatocellular carcinoma development in chronic hepatitis B patients under antiviral therapy
    Li, Yun
    Zhu, Qian
    Tang, Jie
    Guo, De-Liang
    Duan, Rui
    Liu, Jian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (03): : 1356 - 1364
12345